SLC39A9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.772390E-01
Normal-vs-Stage2
2.880800E-01
Normal-vs-Stage3
7.826200E-01
Normal-vs-Stage4
3.256000E-01
Stage1-vs-Stage2
2.479800E-01
Stage1-vs-Stage3
1.189430E-01
Stage1-vs-Stage4
6.776000E-01
Stage2-vs-Stage3
1.084750E-01
Stage2-vs-Stage4
7.538200E-01
Stage3-vs-Stage4
2.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.524200E-01
Normal-vs-AfricanAmerican
3.212800E-01
Normal-vs-Asian
4.696400E-01
Caucasian-vs-AfricanAmerican
7.982800E-01
Caucasian-vs-Asian
4.235400E-01
AfricanAmerican-vs-Asian
6.747400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.912600E-01
Normal-vs-Female
3.848400E-01
Male-vs-Female
5.926600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.244630E-01
Normal-vs-Age(41-60Yrs)
2.416000E-01
Normal-vs-Age(61-80Yrs)
4.349000E-01
Normal-vs-Age(81-100Yrs)
3.197600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.814000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.251600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.765390E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.709800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.838600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.124400E-01
Normal-vs-Daily Drinker
3.667400E-01
Normal-vs-Weekly Drinker
6.274200E-01
Normal-vs-Occasional Drinker
1.825050E-01
Normal-vs-Social Drinker
4.663200E-01
Non Drinker-vs-Daily Drinker
1.892620E-01
Non Drinker-vs-Weekly Drinker
9.486200E-01
Non Drinker-vs-Occasional Drinker
1.972270E-02
Non Drinker-vs-Social Drinker
2.365200E-01
Daily Drinker-vs-Weekly Drinker
3.400200E-01
Daily Drinker-vs-Occasional Drinker
1.660990E-01
Daily Drinker-vs-Social Drinker
5.664200E-01
Weekly Drinker-vs-Occasional Drinker
4.601700E-02
Weekly Drinker-vs-Social Drinker
2.675000E-01
Occasional Drinker-vs-Social Drinker
7.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.521600E-01
Normal-vs-Grade 2
2.307900E-02
Normal-vs-Grade 3
2.040300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.703180E-01
Grade 1-vs-Grade 3
2.843400E-01
Grade 1-vs-Grade 4
2.521600E-01
Grade 2-vs-Grade 3
3.909800E-01
Grade 2-vs-Grade 4
2.307900E-02
Grade 3-vs-Grade 4
2.040300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.729200E-01
Normal-vs-NonDiabetic
3.278400E-01
Diabetic-vs-NonDiabetic
8.192000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.582200E-01
Normal-vs-NoPancreatitis
3.662600E-01
Pancreatitis-vs-NoPancreatitis
5.559600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.032600E-01
Normal-vs-N1
3.008800E-01
N0-vs-N1
2.971000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.865800E-02
Normal-vs-TP53-NonMutant
3.443400E-01
TP53-Mutant-vs-TP53-NonMutant
5.188600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
